Stance Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Stance Capital's DXCM Position: Q3 2026 in Review
Stance Capital sold out of DexCom (DXCM) in Q3 2026, closing a stake of 100 shares — an estimated $6.74K sold.
Stance Capital first reported a position in DXCM in Q3 2025 and held it in 3 quarters. The position peaked at $44.8K in Q3 2025. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- Stance Capital reported no remaining DexCom position as of Q3 2026 after selling out during the quarter.
- Stance Capital sold 100 DexCom shares in Q3 2026, an estimated $6.74K.
- Stance Capital first reported a position in DexCom in Q3 2025 and held it in 3 quarters.
- Stance Capital's DexCom position peaked at $44.8K in Q3 2025.
- 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on Stance Capital's 13F filing for Q3 2026, filed 16 Nov 2026.